Evaluation of Serum and Gene Expression of Galectin-4, Interleukin-27, and Complement-7 in Hepatitis C Virus-Infected Egyptian Patients.
Marwa Sayed Abdel-TawabHanan H FouadDalia Abdelhamid OmranAml E AbdouShaimaa Mohamed ZaiedAlaa A MohamedPublished in: BioMed research international (2020)
LEG4 and IL-27 showed significant negative correlations with the viral load, which could be an immune response to the control of the extent of hepatic inflammation, thus creating a potential novel immunotherapeutic approach in HCV infection for further studies or therapeutic clinical trials.
Keyphrases
- hepatitis c virus
- gene expression
- clinical trial
- end stage renal disease
- human immunodeficiency virus
- ejection fraction
- newly diagnosed
- chronic kidney disease
- oxidative stress
- peritoneal dialysis
- prognostic factors
- randomized controlled trial
- patient reported outcomes
- climate change
- antiretroviral therapy
- case control
- patient reported